![Joshua Muia: Two posters on the enzyme ADAMTS13 being a biomarker in sepsis at ISTH](https://oncodaily.com/pub/uploads/2024/06/1719186949685-1.jpg)
Photo from Joshua Muia/LinkedIn
Jun 30, 2024, 12:42
Joshua Muia: Two posters on the enzyme ADAMTS13 being a biomarker in sepsis at ISTH
Joshua Muia, Associate Investigator at Versiti Blood Research Institute, posted on LinkedIn:
“I am thrilled to attend the 2024 International Society on Thrombosis and Haemostasis (ISTH) Congress ISTH2024 inBangkok, Thailand. My student Frida Miranda (Oklahoma State University, Center for Health Sciences) and I presented two posters on a newly developed multiplex assay of the enzyme ADAMTS13 and ADAMTS13 being a biomarker in Sepsis. Frida’s Outstanding Abstract was recognized with a Career Travel Award and ISTH 2021 Philadelphia Congress Local Organizing Committee Legacy Fund Award.”
Source: Joshua Muia/LinkedIn
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023